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OBJECTIVES: We previously reported recent increases in outpatient utilization for 
ischemic stroke. We examined corresponding trends in ischemic stroke-related inpa-
tient utilization using national US data. METHODS: We identiﬁed all US hospitaliza-
tions for ischemic stroke (IS) [ICD-9-CM codes 433.x1, 434, and 436] in adults aged 
≥18 years using data from the Healthcare Cost and Utilization Project-Nationwide 
Inpatient Sample for years 2000 to 2005. Rates of IS-related hospitalizations were 
calculated by number of IS-related hospital admissions divided by yearly population 
estimates from US Census data. Rates are per 1000 and age-adjusted to the 2000 US 
Standard Population. We examined trends in IS-related hospitalizations, exploring 
sociodemographic and geographic variability based on patient (race, age, gender, 
insurance) and hospital (region, urban/rural location) characteristics. RESULTS: In 
2004–2005, an estimated 0.83 million IS-related hospitalizations were identiﬁed, 
representing a 10% decline from 0.92 million hospitalizations in 2000–2001. The 
proportion of IS-related hospitalizations declined among adults aged 65–84 years from 
57% (population estimate, 526,743) in 2000–2001 to 52% (435,477) in 2004–2005. 
This decline was partially offset by an increased proportion of IS-related hospitaliza-
tions by adults aged 45–64 years from 21% (190,000) in 2000–2001 to 24% 
(202,000) in 2004–2005. From 2000–2001 to 2004–2005, the proportion of IS-
related hospitalizations by whites decreased from 58% (534,000) to 53% (445,000) 
but those by Blacks remained relatively stable at 10% (95,000). The frequency of 
IS-related admissions to urban hospitals increased slightly from 81% in 2000–2001 
to 84% in 2004–2005. Overall, the US age-adjusted IS-related hospitalization rate 
declined from 2.3/1,000 in 2000 to 1.9/1,000 in 2005, representing a 17% decrease 
over the 6-year period. CONCLUSIONS: From 2000–2001 to 2004–2005, IS-related 
hospitalizations declined substantially, primarily among whites and the elderly, 
but increased among middle-aged adults. Further research is needed to understand 
the causes and consequences of observed inpatient and outpatient utilization trends 
for IS.
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OBJECTIVES: The purpose of this study was to ﬁnd risk factors associated with high 
prevalence of hypertension. METHODS: The analysis was based on the 2007 Korean 
National Health and Nutrition Examination Survey (K-NHANES), a cross-sectional 
survey of the civilian, non-institutionalized population in Korea including an in-home 
interview and a clinic examination which included measurement of blood pressure. 
The logistic regressions were utilized to ﬁnd association of various risk factors and 
hypertension among the Korean population. All results were weighted considering 
survey design of K-NHANES such as stratiﬁcation and primary survey unit. RESULTS: 
The dataset consisted of a total of 2797 individuals, 23.26% of elderly (≥65 years 
old) and 57.5% of female. About 32% of people were overweight (BMI≥25 kg/m2) 
or obese(BMI≥30 kg/m2), and the prevalence in diabetes and kidney disease in the 
sample were 7.5% and 0.6%, respectively. According to the regression results, age, 
BMI, and comorbid conditions such as diabetes and kidney diseases were signiﬁcantly 
related to hypertension in the Korean Populace. The elderly Koreans were three times 
as likely to be diagnosed with hypertension relative to the nonelderly population (odds 
ratio (OR): 2.86, p-value <0.001). Obese or overweight Koreans were two times more 
prone to have hypertension relative to normal weight individuals (OR: 2.44, p-value 
<0.001). People with diabetes had a risk factor of contracting hypertension which was 
four times than people without diabetes (OR: 3.53, p-value <0.001). Finally, patients 
with kidney disease were seventeen times more likely to be diagnosed with hyperten-
sion relative to those without kidney disease(OR: 16.87, p-value = 0.012). CONCLU-
SIONS: The results provide evidence of the association between varying risk factors 
and hypertension among Koreans, and insights for both public health ofﬁcials and 
physicians to treat or prevent hypertension patients.
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OBJECTIVES: To assess the impact of switching between an ACE Inhibitor (ACEI) 
and an Angiotensin Receptor Blocker (ARB) on blood pressure (BP) control and 
cardiovascular CV events in a real-world setting. METHODS: Records from a longi-
tudinal population-based database of more than 170,000 patients in over 53 family 
practice clinics in southwestern Ontario, Canada were analyzed. These records con-
tained chart-abstracted information such as visit diagnosis, BP, medications and con-
sultation notes. The records from 8,388 adult hypertensive patients treated in mono 
or combination therapy and who switched between an ACEI and an ARB, (while 
keeping other agents constant) were included. Hypertension was deﬁned as a BP 
exceeding 140/90 mmHg, chart entry of a diagnosis of hypertension, or use of anti-
hypertensive medication. Systolic and diastolic BPs and the number of patients who 
experienced a CV event were recorded. RESULTS: Reductions in mean systolic BP 
when patients were switched from ACEI to ARB were 8 mmHg (p < 0.002), 7 mmHg 
(p < 0.005), and 8 mmHg (p < 0.005) in mono, dual and tri-therapy respectively while 
patients who were switched from ARB to ACEI had change in of +1 mmHg, −8 mmHg 
(p < 0.001) and −5 mmHg (p < 0.005) in mono, dual and tri-therapy respectively. 
More ARB to ACEI switchers experienced at least one CV event (2.5% versus 0.5% 
in patients who remain on an ARB monotherapy (p = 0.001) and 1.8% versus 0.8% 
in patients who remain on an ARB based dual therapy (p = 0.002)). CONCLUSIONS: 
In a real-world setting, switching patients from an ACEI to an ARB had a positive 
impact on mean systolic BP reduction. When compared to those who remain on an 
ARB, patients who switched from an ARB to an ACEI experienced more CV events.
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OBJECTIVES: To determine the prevalence of patients diagnosed with atrial ﬁbrilla-
tion, their demographic characteristics and pharmacologic management. METHODS: 
Records from a longitudinal population-based database of more than 170,000 patients 
in over 53 family practice clinics in southwestern Ontario, Canada were analyzed. 
These records contained chart-abstracted information such as visit diagnosis, medica-
tions and consultation notes. Patients with atrial ﬁbrillation were identiﬁed by ICD9 
code, the presence of anti-arrhythmic medication or diagnostic information revealing 
atrial ﬁbrillation. Comparison included patient characteristics (CV history of hyper-
tension, heart failure, dyslipidemia, conronary heart disease, diabetes; presence of 
concomitant medications including oral anti-coagulants, beta blockers, ACE inhibit-
ors, and ARBs, diuretics, Digoxin, calcium channel blockers, statins, and NSAIDS) by 
treatment with anti-arrhythmic drugs including, amiodarone, sotalol, propafanone, 
and ﬂecainide. RESULTS: A total of 4922 patients with the diagnosis of atrial ﬁbril-
lation revealed a prevalence of 3% in our cohort. Mean age of those with atrial 
ﬁbrillation was 78 years with 53% male. 42% of patients with atrial ﬁbrillation also 
had diagnosis of hypertension; 19% had diagnosis of congestive heart failure (with 
the majority of these in Class 3 and 4); 28% had a history of coronary artery disease; 
18% had a history of diabetes; and 20% had a diagnosis of dyslipidemia. Concomitant 
medications included oral anticoagulant (28%), statin (28%) and digoxin (22%). 
Most patients diagnosed with atrial ﬁbrillation were on rate control medications with 
sotolol being most common followed by amiodarone, propafenone and ﬂecainide. 
There is no difference in the distribution of patients with previous cardiovascular 
history or concomitant medications across anti-arrhythmic drugs used. CONCLU-
SIONS: In patients with atrial ﬁbrillation, there is a high rate of concomitant cardio-
vascular morbidity. Most patients are treated with anti-arrhythmic medications 
primarily sotalol and amiodarone. Comorbidity or concomitant medications do not 
appear to inﬂuence the choice of the anti-arrhythmic used.
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OBJECTIVES: The purpose of our present study was to investigate whether the time 
of onset of an acute cerebrovascular event demonstrates a seasonal variation, and 
whether the occurrence of this is inﬂuenced by certain meteorological factors. 
METHODS: We have examined patients admitted to the Department of Neurology 
in Hungary between 2005 and 2007 with the diagnosis of a cerebral hemorrhage (n 
= 11,604) or a transient ischemic attack (n = 12,513). Data was collected from the 
database of the Hungarian National Health Insurance Fund on the basis of Interna-
tional Classiﬁcation of Diseases (ICD). (ICD codes G4580, G4590, I6100-I6190). 
Meteorological data (temperature, atmospheric pressure, relative humidity) was 
retrieved from the National Meteorology Service. Statistical analysis was carried out 
with SPSS 14.0 for Windows. RESULTS: Analysis of meteorological data showed that 
an increase in average temperature on the previous day resulted in a notable drop of 
cerebral hemorrhage incidence during all seasons (p < 0.05), while in case of transient 
ischemic attack such a decrease only occurred during Summer (p < 0.05). Examining 
atmospheric pressure and relative humidity (p < 0.05) only a demonstrative variation 
was found in case of cerebral infarction. CONCLUSIONS: In summary, our results 
indicate that the incidence of cerebral infarction, cerebral hemorrhage, and a transient 
ischemic attack show a typical variation depending on the season of the year and 
temperature as well have an inﬂuence in the development of different cerebrovascular 
events.
